None of the four companies have confirmed nor denied the report.
J&J researchers did state in NEJM that there is insufficient evidence to link six cases of cerebral venous sinus thrombosis (CVST) paired with low platelet counts to the company’s COVID-19 vaccine. Approximately seven million people in the U.S. have received the vaccine.
AstraZeneca (LON:AZN) is said to have been interested in allying wit…